Neurofilament heavy chain-like messenger RNA and protein are present in benign prostate and down-regulated in prostatic carcinoma.
Rosemary L. Schleicher(Centers for Disease Control and Prevention), Vijay Varma, Michael T. Fallon, Ming Zhang(Houston Methodist), Wanlong Tan(Nanfang Hospital), M. Zheng, Claudiu Bandea, David G. Bostwick(University of Córdoba), Stephen Hunter
PubMed
August 15, 1997
Cited by 13
Related Papers
Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study
|The Lancet Oncology|2020|631
Atypical Small Acinar Proliferation Suspicious for Malignancy in Prostate Needle Biopsies
|The American Journal of Surgical Pathology|1997|203
Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms
|Drug Resistance Updates|2023|202